Related Experiment Videos
Improved healing of tympanic membrane perforations with basic fibroblast growth factor
1Department of Surgery/Otolaryngology, UCSD School of Medicine, La Jolla.
Growth Factors (Chur, Switzerland)
|January 1, 1991
Summary
Basic fibroblast growth factor (FGF) accelerates tympanic membrane (TM) perforation healing. This growth factor promotes faster repair by stimulating connective tissue proliferation in TM perforations.
Area of Science:
- Otolaryngology
- Regenerative Medicine
- Wound Healing Research
Background:
- Tympanic membrane (TM) perforations can impair hearing and are prone to delayed healing.
- Basic fibroblast growth factor (FGF) is a signaling protein known to play a role in tissue repair and regeneration.
Purpose of the Study:
- To investigate the efficacy of basic fibroblast growth factor (FGF) in promoting the healing of tympanic membrane (TM) perforations.
- To evaluate the effect of basic FGF on TM perforation repair rates in a guinea pig model.
Main Methods:
- Two models of TM perforations (1-mm round and 2-mm with inward-folded borders) were created in 51 guinea pigs.
- Topical application of either saline (control) or basic FGF (1 microgram) was administered daily via gelfoam overlays.
- Lesion repair was assessed at 3, 5, and 8 days post-surgery.
Main Results:
- Basic fibroblast growth factor (FGF) significantly accelerated the healing process of tympanic membrane (TM) perforations.
- Histological evaluation revealed that basic FGF induced rapid proliferation of the subepithelial connective tissue layer.
- The pro-healing effects of basic FGF were observed in both simple and intentionally delayed healing perforation models.
Conclusions:
- Basic fibroblast growth factor (FGF) is a potent therapeutic agent for enhancing tympanic membrane (TM) perforation repair.
- The mechanism of action involves stimulating subepithelial connective tissue growth, leading to faster closure of TM defects.
- Basic FGF holds promise for clinical applications in managing TM injuries and improving hearing outcomes.